Tyra Biosciences, Inc. (TYRA)
TYRA Stock Price Chart
Explore Tyra Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze TYRA price movements and trends.
TYRA Company Profile
Discover essential business fundamentals and corporate details for Tyra Biosciences, Inc. (TYRA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Sept 2021
Employees
60.00
Website
https://www.tyra.bioCEO
Todd Harris
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.
TYRA Financial Timeline
Browse a chronological timeline of Tyra Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.50.
Earnings released on 14 Aug 2025
EPS came in at -$0.47 surpassing the estimated -$0.53 by +11.32%.
Earnings released on 8 May 2025
EPS came in at -$0.47 surpassing the estimated -$0.49 by +4.08%.
Earnings released on 27 Mar 2025
EPS came in at -$0.43 surpassing the estimated -$0.48 by +10.42%.
Earnings released on 7 Nov 2024
EPS came in at -$0.41 falling short of the estimated -$0.40 by -2.50%.
Earnings released on 7 Aug 2024
EPS came in at -$0.32 surpassing the estimated -$0.41 by +21.95%.
Earnings released on 9 May 2024
EPS came in at -$0.35 surpassing the estimated -$0.46 by +23.91%.
Earnings released on 19 Mar 2024
EPS came in at -$0.53 falling short of the estimated -$0.48 by -10.42%, while revenue for the quarter reached $502.00K .
Earnings released on 7 Nov 2023
EPS came in at -$0.49 falling short of the estimated -$0.35 by -40.00%.
Earnings released on 10 Aug 2023
EPS came in at -$0.31 surpassing the estimated -$0.34 by +8.82%.
Earnings released on 4 May 2023
EPS came in at -$0.28 surpassing the estimated -$0.37 by +24.32%.
Earnings released on 22 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.35 by +11.43%.
Earnings released on 3 Nov 2022
EPS came in at -$0.30 surpassing the estimated -$0.41 by +26.83%.
Earnings released on 4 Aug 2022
EPS came in at -$0.36 falling short of the estimated -$0.33 by -9.09%.
Earnings released on 5 May 2022
EPS came in at -$0.36 falling short of the estimated -$0.20 by -80.00%.
Earnings released on 3 Mar 2022
EPS came in at -$0.24 falling short of the estimated -$0.21 by -14.29%.
Earnings released on 3 Nov 2021
EPS came in at -$0.72 falling short of the estimated -$0.29 by -148.28%.
Earnings released on 15 Sept 2021
EPS came in at -$0.19 .
Earnings released on 30 Jun 2021
EPS came in at -$0.15 .
Earnings released on 31 Dec 2020
EPS came in at -$0.16 .
Earnings released on 30 Sept 2020
EPS came in at -$0.10 .
TYRA Stock Performance
Access detailed TYRA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.